Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1584

1.

A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.

DelBello MP, Chang K, Welge JA, Adler CM, Rana M, Howe M, Bryan H, Vogel D, Sampang S, Delgado SV, Sorter M, Strakowski SM.

Bipolar Disord. 2009 Aug;11(5):483-93. doi: 10.1111/j.1399-5618.2009.00728.x.

PMID:
19624387
2.
3.

Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).

Thase ME, Macfadden W, Weisler RH, Chang W, Paulsson B, Khan A, Calabrese JR; BOLDER II Study Group..

J Clin Psychopharmacol. 2006 Dec;26(6):600-9. Erratum in: J Clin Psychopharmacol. 2007 Feb;27(1):51.

PMID:
17110817
4.

Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.

McIntyre RS, Konarski JZ, Jones M, Paulsson B.

J Affect Disord. 2007;100 Suppl 1:S5-14.

PMID:
17391773
5.

A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.

Bowden CL, Grunze H, Mullen J, Brecher M, Paulsson B, Jones M, Vågerö M, Svensson K.

J Clin Psychiatry. 2005 Jan;66(1):111-21.

PMID:
15669897
6.

Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.

Cutler AJ, Datto C, Nordenhem A, Minkwitz M, Acevedo L, Darko D.

Clin Ther. 2011 Nov;33(11):1643-58. doi: 10.1016/j.clinthera.2011.10.002.

PMID:
22054797
7.

A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).

Young AH, McElroy SL, Bauer M, Philips N, Chang W, Olausson B, Paulsson B, Brecher M; EMBOLDEN I (Trial 001) Investigators..

J Clin Psychiatry. 2010 Feb;71(2):150-62. doi: 10.4088/JCP.08m04995gre.

PMID:
20122369
8.

Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.

Vieta E, Calabrese JR, Goikolea JM, Raines S, Macfadden W; BOLDER Study Group..

Bipolar Disord. 2007 Jun;9(4):413-25.

PMID:
17547587
9.

A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder.

DelBello MP, Adler CM, Whitsel RM, Stanford KE, Strakowski SM.

J Clin Psychiatry. 2007 May;68(5):789-95.

PMID:
17503991
10.

Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.

McElroy SL, Martens BE, Winstanley EL, Creech R, Malhotra S, Keck PE Jr.

J Affect Disord. 2010 Jul;124(1-2):157-63. doi: 10.1016/j.jad.2009.11.014.

PMID:
19963274
11.

A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania.

Delbello MP, Schwiers ML, Rosenberg HL, Strakowski SM.

J Am Acad Child Adolesc Psychiatry. 2002 Oct;41(10):1216-23.

PMID:
12364843
12.

Quetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies.

Suppes T, Hirschfeld RM, Vieta E, Raines S, Paulsson B.

World J Biol Psychiatry. 2008;9(3):198-211.

PMID:
17853277
13.

A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).

McElroy SL, Weisler RH, Chang W, Olausson B, Paulsson B, Brecher M, Agambaram V, Merideth C, Nordenhem A, Young AH; EMBOLDEN II (Trial D1447C00134) Investigators..

J Clin Psychiatry. 2010 Feb;71(2):163-74. doi: 10.4088/JCP.08m04942gre.

PMID:
20122366
14.

Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania.

Ketter TA, Jones M, Paulsson B.

J Affect Disord. 2007;100 Suppl 1:S45-53.

PMID:
17383011
15.

A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania.

DelBello MP, Kowatch RA, Adler CM, Stanford KE, Welge JA, Barzman DH, Nelson E, Strakowski SM.

J Am Acad Child Adolesc Psychiatry. 2006 Mar;45(3):305-13.

PMID:
16540815
16.
17.

Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study.

Weisler R, Joyce M, McGill L, Lazarus A, Szamosi J, Eriksson H; Moonstone Study Group..

CNS Spectr. 2009 Jun;14(6):299-313.

PMID:
19668121
18.

Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials.

Weisler RH, Hirschfeld R, Cutler AJ, Gazda T, Ketter TA, Keck PE, Swann A, Kalali A; SPD417 Study Group..

CNS Drugs. 2006;20(3):219-31.

PMID:
16529527
19.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
20.

Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.

Sussman N, Mullen J, Paulsson B, Vågerö M.

J Affect Disord. 2007;100 Suppl 1:S55-63.

PMID:
17383736

Supplemental Content

Support Center